Alta, Rowena O.
HRN: 18-43-49 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2025
CEFTAZIDIME 1GM (VIAL)
05/28/2025
06/03/2025
IV
2g
Q8h
CAPMR
Waiting Final Action
05/28/2025
LEVOFLOXACIN 500MG (TAB)
05/28/2025
06/03/2025
PO
500mg
Q8h
CAPMR
Waiting Final Action